Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum The Medipattern Corporation V.MKI

TSXV:MKI - Post Discussion

View:
Post by knoll on Aug 29, 2012 11:31pm

volume

Stockhouse shows volume at 144,000 but Bloomburg shows it at 187000. Been noticing a discrepance for a while now. Anyone else notice this. Anyone know why this is. Other stocks as well. Stockhouse shows Cardiocom as 400,000 Bloomburg shows it as 800,000.

Just wondering if anyone knows.

Comment by xsnrg on Aug 30, 2012 9:11am
Alpha exchange handles a lot of the venture volume. The TSX and hence stockhouse doesn't report on it but if you have a bloomie machine it will capture ALL the volume. You need to check the ahpla website for MKI info as well, it handles pretty much all the day orders so if your smart you can buy or sell stealthy and under the radar if you figure it out. In some cases your right you could be ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities